Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate
Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate Basic information
- Product Name:
- Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate
- Synonyms:
-
- 2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene]
- ethyl 2-chloro-2-[(4-methoxyphenyl)hydrazinylidene]acetate
- Apixaban Impurity B
- (Z)-Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate (Apixaban)
- Apixaban-2
- 1-(4-methoxyphenyl)-4-(2-((4-(2-oxopiperidin-1-yl)phenyl)amino)ethyl)-1H-pyrazole-3,5-dicarboxamide
- Chloro[(4-methoxyphenyl)hydrazono]acetic acid ethyl ester
- Ethyl chloro[(4-methoxyphenyl)hydrazono]acetate
- CAS:
- 27143-07-3
- MF:
- C11H13ClN2O3
- MW:
- 256.69
- EINECS:
- 608-053-7
- Product Categories:
-
- 27143-07-3
- Mol File:
- 27143-07-3.mol
Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate Chemical Properties
- Melting point:
- 94℃
- Boiling point:
- 349.0±44.0 °C(Predicted)
- Density
- 1.23
- storage temp.
- 2-8°C
- solubility
- Chloroform (Sparingly), Methanol (Slightly)
- form
- Solid
- pka
- 11.63±0.10(Predicted)
- color
- Yellow to Dark Yellow
- InChI
- InChI=1S/C11H13ClN2O3/c1-3-17-11(15)10(12)14-13-8-4-6-9(16-2)7-5-8/h4-7,13H,3H2,1-2H3
- InChIKey
- ATNPZEGMKLGIFA-UHFFFAOYSA-N
- SMILES
- C(OCC)(=O)C(Cl)=NNC1=CC=C(OC)C=C1
Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate Usage And Synthesis
Physical properties
Light yellow to dark yellow solid
Uses
Acetic acid, 2-chloro-2-[2-(4-methoxyphenyl)hydrazinylidene], ethyl ester is an ester derivative and can be used as an intermediate in the synthesis of apixaban.
Synthesis
Step-1:Water (600 ml) was added to p-anisidine (100 g) at room temperature and the resulting mixture was cooled to 10°C, followed by the addition of concentrated hydrochloric acid (133.5 g). The resulting mixture was cooled to —5°C to 0°C, followed by portion-wise addition of 40 % aqueous sodium nitrite solution over 45 minutes to 1 hour. The resulting mass was stirred for 1 hour 30 minutes at —5°C to0°C, followed by slow addition of 11 % sulfamic acid solution over 1 hour to 1 hour 30 minutes to produce a reaction mass (first part).Step-2:Sodium acetate (146 g) was added to water (300 ml) at room temperature and then stirred for 10 minutes to 15 minutes, followed by the addition of ethyl 2-chloroacetoacetate (160.4g) and acetone (300 ml) at room temperature to form a reaction mixture. The resulting mixture was cooled to 0°C. The resulting mixture was added to the reaction mass (first part) obtained in step-i at —5°C to 0°C and then stirred for 1 hour at the same temperature. Acetone (200 ml) was added to the resulting mass and stirred for 30 minutes at —5°C to 0°C. The resulting mass was settled for 5 hours at —5°C to 0°Cand then filtered the solid. Methanol (150 ml) was added to the resulting solid at room temperature and then stirred for 2 hours at the same temperature. Ethyl 2-chloro-2-(2-(4-methoxyphenyl) hydrazone)acetate was obtained through further purity.
Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetateSupplier
- Tel
- 18954159893
- demi@pharmachemm.com
- Tel
- 13327700685
- sales@vcarepharmatech.com
- Tel
- 5108538618
- suger.wang@chemfuture.com
- Tel
- 023-88654579 13637703915
- 375097861@qq.com
- Tel
- 0531-88113608 17854192669
- sales07@pharmachemm.com
Ethyl 2-chloro-2-(2-(4-methoxyphenyl)hydrazono)acetate(27143-07-3)Related Product Information
- Apixaban Impurity 20
- (4,4'‐didodecyl‐2,2'‐ bithiophene‐5,5'‐ diyl)bis(triMethylstann ane)
- 1-(4-Methoxyphenyl)-6-(4-(2-Methyl-6-oxopiperidin-1-yl)phenyl)-7-oxo-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxaMide
- Apixaban Impurity 13
- ETHYL (2E)-CHLORO[(4-CHLOROPHENYL)HYDRAZONO]ACETATE
- 1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid
- Apixaban IMpurity 3
- 1-(4-chlorophenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxaMide
- Apixaban Impurity 11
- Apixaban IMpurity 5 (BMS-591329-01)
- 3-Morpholino-1-(4-(2-oxopiperidin-1-yl)phenyl)-5,6-dihydropyridin-2(1H)-one
- 3-Morpholino-1-(4-nitrophenyl)-5,6-dihydropyridin-2(1H)-one
- 1-(4-AMinophenyl)-5,6-dihydro-3-(4-Morpholinyl)-2(1h)-pyridinone
- 1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid ethyl ester
- 1-(4-Nitrophenyl)-2-piperidinone
- 4,5,6,7-Tetrahydro-1-(4-methoxyphenyl)-6-[4-(5-methyl-2-oxo-1-piperidinyl)phenyl]-7-oxo-1H-pyrazolo[3,4-c]pyridine-3-carboxamide
- (S)-4-(4-(5-(Aminomethyl)-2-oxooxazolidin-3-yl)phenyl)morpholin-3-one.HCl
- (R)-3-Piperidinamine dihydrochloride